Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc. July 23, 2021 Read More
Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021 July 14, 2021 Read More
Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter July 13, 2021 Read More
Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay June 28, 2021 Read More
Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses June 16, 2021 Read More
Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference May 27, 2021 Read More
Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples May 17, 2021 Read More
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021 May 7, 2021 Read More
Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready LAMP Mix April 28, 2021 Read More
Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021 April 19, 2021 Read More
